DME competitive bidding
This article was originally published in The Gray Sheet
Executive Summary
House provision in Medicare bill implementing a national competitive bidding program would be "difficult" to implement as written, Senate Finance Committee Democratic Counsel Elizabeth Fowler remarks at Alliance for Health Reform briefing July 1 in Washington, D.C. The device industry opposes the measure (1"The Gray Sheet" June 30, 2003, p. 7). A House/Senate conference on the bill is expected to begin the week of July 7...
You may also be interested in...
Medicare Reform Bills Head To Conference; Competitive Bidding Fuels Debate
AdvaMed will work closely with Sens. Rick Santorum (R-Penn.) and Blanche Lincoln (D-Ark.) to ensure language easing criteria for new technology "add-on" payments is included in the final Medicare bill
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.